AI assistant
Merck & Co., Inc. — Director's Dealing 2021
Apr 7, 2021
284_dirs_2021-04-07_24f754f0-9a35-452e-b0a3-16d389a09fe4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-04-01
Reporting Person: Litchfield Caroline (EVP & CFO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18242.1241 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2021-05-04 | Common Stock (1039) | Direct | |
| Restricted Stock Unit | $ | 2022-05-03 | Common Stock (1500) | Direct | |
| Restricted Stock Unit | $ | 2023-03-01 | Common Stock (2520) | Direct | |
| Stock Option (Right to Buy) | $58.22 | 2024-05-01 | Common Stock (22008) | Direct | |
| Stock Option (Right to Buy) | $59.86 | 2025-04-30 | Common Stock (37152) | Direct | |
| Stock Option (Right to Buy) | $54.68 | 2026-05-09 | Common Stock (40747) | Direct | |
| Stock Option (Right to Buy) | $63.97 | 2027-05-04 | Common Stock (25678) | Direct | |
| Stock Option (Right to Buy) | $57.75 | 2028-05-03 | Common Stock (21957) | Direct | |
| Stock Option (Right to Buy) | $80.00 | 2029-05-02 | Common Stock (16936) | Direct | |
| Stock Option (Right to Buy) | $77.67 | 2030-04-30 | Common Stock (19709) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
F6: The option became exercisable in equal installments on 5/2/2015, 5/2/2016 and 5/2/2017.
F7: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.
F8: The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.
F9: The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.
F10: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F11: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
F12: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.